Related Content
September 12, 2017 — Inclisiran lowers low-density lipoprotein (LDL, or “bad”) cholesterol for up to one year in ...
September 12, 2017
January 6, 2016 — The Medicines Company announced Dec. 18 it has entered into a purchase agreement pursuant to which ...
January 06, 2016November 24, 2015 —The U.S. Court of Appeals has overturned a federal circuit court’s decision in The Medicines Company ...
November 24, 2015
July 22, 2015 — The Medicines Company announced the U.S. Court of Appeals for the Federal Circuit Court has ruled ...
July 22, 2015
June 22, 2015 - The Medicines Company announced the approval of cangrelor (Kengreal) by the U.S. Food and Drug ...
June 22, 2015
April 29, 2015 — The Medicines Company announced that the U.S. Food and Drug Administration (FDA) Cardiovascular and ...
April 29, 2015March 30, 2015 — The Medicines Company announced that the European Commission has granted marketing authorization for ...
March 30, 2015
November 2, 2012 — Patients who receive a drug-eluting stent (DES) and demonstrate low levels of platelet inhibition are ...
November 02, 2012
November 15, 2011 — Data from the BRIDGE clinical trial demonstrate that intravenous use of the drug cangrelor was ...
November 15, 2011
October 8, 2010 – New data from the HORIZONS-AMI trial shows that administering the anticoagulant bivalirudin (Angiomax) ...
October 08, 2010© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now